Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹2,023Cr
Rev Gr TTM
Revenue Growth TTM
8.29%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

INSECTICID
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 8.6 | 14.1 | 19.5 | 0.4 | -9.7 | 2.6 | -9.9 | -0.1 | 31.7 | 5.2 | 1.7 | 7.6 |
| 330 | 594 | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 |
Operating Profit Operating ProfitCr |
| -9.4 | 7.1 | 11.8 | 7.3 | 3.3 | 11.0 | 14.3 | 8.6 | 7.9 | 12.2 | 14.0 | 7.1 |
Other Income Other IncomeCr | 0 | 4 | 0 | 1 | 4 | 3 | 2 | 0 | 3 | 4 | 3 | 1 |
Interest Expense Interest ExpenseCr | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 |
Depreciation DepreciationCr | 7 | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 |
| -39 | 40 | 72 | 17 | 4 | 66 | 82 | 22 | 22 | 77 | 79 | 14 |
| -10 | 10 | 19 | 5 | -4 | 17 | 21 | 5 | 8 | 19 | 20 | 4 |
|
Growth YoY PAT Growth YoY% | -231.2 | -23.9 | 18.6 | 31.4 | 126.5 | 69.4 | 15.7 | 41.1 | 79.0 | 17.7 | -3.9 | -39.6 |
| -9.7 | 4.5 | 7.6 | 3.4 | 2.9 | 7.5 | 9.8 | 4.9 | 3.9 | 8.4 | 9.3 | 2.7 |
| -9.9 | 9.8 | 17.9 | 4.2 | 2.6 | 16.6 | 20.8 | 6.0 | 4.8 | 20.0 | 20.3 | 3.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 2.4 | 0.6 | 8.0 | 11.2 | 14.2 | 4.2 | 5.9 | 19.8 | 9.2 | 1.7 | 3.6 |
| 854 | 896 | 883 | 925 | 1,006 | 1,207 | 1,268 | 1,334 | 1,679 | 1,804 | 1,779 | 1,843 |
Operating Profit Operating ProfitCr |
| 11.5 | 9.3 | 11.2 | 13.8 | 15.7 | 11.4 | 10.7 | 11.3 | 6.8 | 8.3 | 11.1 | 11.1 |
Other Income Other IncomeCr | 1 | 1 | 7 | 4 | 1 | 3 | -2 | 5 | 2 | 10 | 8 | 11 |
Interest Expense Interest ExpenseCr | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 15 |
Depreciation DepreciationCr | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 33 |
| 64 | 50 | 82 | 118 | 153 | 111 | 120 | 141 | 84 | 132 | 193 | 193 |
| 9 | 11 | 23 | 34 | 31 | 24 | 26 | 34 | 21 | 30 | 51 | 51 |
|
| | -27.8 | 50.8 | 41.2 | 45.7 | -29.2 | 8.0 | 14.4 | -41.2 | 61.9 | 38.7 | -0.3 |
| 5.7 | 4.0 | 6.0 | 7.8 | 10.3 | 6.4 | 6.6 | 7.1 | 3.5 | 5.2 | 7.1 | 6.8 |
| 43.2 | 19.1 | 28.9 | 27.2 | 39.6 | 28.0 | 30.3 | 24.1 | 21.4 | 34.6 | 48.4 | 48.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| 278 | 388 | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 984 | 1,056 | 1,174 |
Current Liabilities Current LiabilitiesCr | 556 | 475 | 489 | 425 | 674 | 539 | 585 | 508 | 760 | 656 | 778 | 756 |
Non Current Liabilities Non Current LiabilitiesCr | 74 | 52 | 25 | 28 | 20 | 23 | 21 | 19 | 19 | 44 | 36 | 37 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 662 | 675 | 715 | 719 | 1,062 | 978 | 1,086 | 1,003 | 1,232 | 1,248 | 1,425 | 1,494 |
Non Current Assets Non Current AssetsCr | 259 | 261 | 263 | 281 | 293 | 316 | 340 | 393 | 464 | 465 | 473 | 503 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -6 | 86 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 |
Investing Cash Flow Investing Cash FlowCr | -34 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 |
Financing Cash Flow Financing Cash FlowCr | 36 | -64 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 |
|
Free Cash Flow Free Cash FlowCr | -40 | 67 | -10 | 154 | -171 | 213 | 108 | 68 | -97 | 143 | 59 |
| -10.1 | 216.9 | 6.7 | 215.4 | -108.4 | 278.3 | 165.4 | 125.5 | -16.8 | 182.7 | 65.8 |
CFO To EBITDA CFO To EBITDA% | -5.0 | 93.3 | 3.6 | 122.8 | -71.1 | 155.2 | 102.0 | 79.5 | -8.7 | 115.0 | 42.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 876 | 644 | 1,098 | 1,422 | 1,363 | 647 | 979 | 1,211 | 1,383 | 1,447 | 1,722 |
Price To Earnings Price To Earnings | 16.0 | 16.7 | 18.4 | 16.9 | 11.1 | 7.5 | 10.4 | 11.3 | 21.9 | 14.2 | 12.1 |
Price To Sales Price To Sales | 0.9 | 0.7 | 1.1 | 1.2 | 1.1 | 0.5 | 0.7 | 0.8 | 0.8 | 0.7 | 0.9 |
Price To Book Price To Book | 3.0 | 1.6 | 2.4 | 2.6 | 2.1 | 0.9 | 1.2 | 1.4 | 1.5 | 1.4 | 1.6 |
| 10.5 | 8.8 | 11.8 | 10.2 | 8.8 | 4.9 | 6.5 | 7.2 | 12.5 | 9.1 | 8.0 |
Profitability Ratios Profitability Ratios |
| 32.8 | 31.7 | 25.3 | 28.9 | 31.1 | 26.0 | 24.8 | 26.4 | 23.1 | 25.5 | 32.0 |
| 11.5 | 9.3 | 11.2 | 13.8 | 15.7 | 11.4 | 10.7 | 11.3 | 6.8 | 8.3 | 11.1 |
| 5.7 | 4.0 | 6.0 | 7.8 | 10.3 | 6.4 | 6.6 | 7.1 | 3.5 | 5.2 | 7.1 |
| 16.6 | 12.9 | 14.9 | 20.6 | 17.6 | 14.7 | 13.7 | 16.0 | 9.0 | 13.0 | 16.8 |
| 18.9 | 9.7 | 12.8 | 15.4 | 18.6 | 11.9 | 11.4 | 12.3 | 6.9 | 10.1 | 13.1 |
| 6.0 | 4.2 | 6.1 | 8.4 | 9.1 | 6.7 | 6.6 | 7.7 | 3.7 | 6.0 | 7.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Insecticides (India) Limited (IIL) is a leading Indian agrochemical company headquartered in New Delhi, operating for over five decades. The company is a major player in crop protection and nutrition, offering over **20 technical** and **140 formulation products** across insecticides, herbicides, fungicides, and plant growth regulators. IIL markets its products under the highly recognized **‘Tractor’ brand**, which enjoys widespread trust among over **4 million farmers** across India.
With a strong **integrated business model**, IIL combines **in-house R&D**, **backward integration**, and **strategic global alliances** to deliver innovative, science-backed agricultural solutions. The company is transitioning from generic products to **high-margin, proprietary formulations**, positioning itself at the forefront of India’s agrochemical innovation.
---
### **Key Strategic Developments (2024–2025)**
#### **Global Collaborations & Partnerships**
IIL has strengthened its technology edge through strategic alliances with global agrochemical leaders:
- **Corteva Agriscience (USA)**: Launched **SPARCLE Insecticide**, a next-generation solution for paddy.
- **Nissan Chemical Corporation (Japan)**: Co-developed **Altair**, a patented pre-emergent herbicide for rice. The partnership, initiated in 2013, has yielded multiple successful products including **PULSOR, HAKAMA, KUNOICHI, HACHIMAN, SHINWA, and IZUKI**.
- **OAT Agrio Co., Ltd. (Japan)**: Partnership to launch **CHAPERONE** and **TADAAKI**, and co-invest in R&D for new agrochemical molecules.
- **Momentive Performance Materials Inc. (USA)**: Marketing collaboration for **AGROSPRED MAX**, a silicone-based super spreader.
#### **Joint Venture & R&D Leadership**
- IIL formed a **joint venture with OAT Agrio** to establish **OAT & IIL India Laboratories Pvt. Ltd.**, a **dedicated R&D center** in India focused on discovering original agrochemical molecules — a rare capability among Indian pesticide firms.
- The company operates **four R&D streams**: **Synthesis, Formulation, Biologicals, and New Molecule Invention**, supported by **DSIR-approved** and **GLP-certified** labs.
- Over **60 scientists** work across R&D centers, with **35+ patents filed** (19 granted), reflecting a long-term innovation strategy.
#### **Manufacturing & Capacity Expansion**
IIL owns an extensive and growing manufacturing footprint:
- **Six formulation units** and **two technical synthesis plants** at **Chopanki (Rajasthan)** and **Dahej (Gujarat)**, enabling backward integration.
- Active ingredient (AI) production includes **Pyrithiobac sodium, Topramezone, and Pyroxasulfone**.
- **Chopanki and Dahej expansions** have increased capacity by over 50%, enhancing cost efficiency and import substitution.
- A new **integrated manufacturing and R&D facility** is under development at **Sotanala, Rajasthan**, designed for **formulations, biologicals, and R&D**.
- Total formulation capacity exceeds **70,000 MT/KL/year**, with technical synthesis at **15,800 MTPA**.
- Investment in **solar power, water recycling**, and **waste reduction** aligns with ESG and sustainability goals.
#### **Product Innovation & Commercial Success**
IIL has successfully launched multiple **"new-generation"** products, many with **patented or exclusive rights**:
- **Altair (Nissan, 2025)**: A breakthrough **pre-emergent herbicide** for paddy, forming a soil barrier with **40–50 days of weed control**. Marketed exclusively in India, co-developed after 8 years of R&D.
- **Shinwa**: IIL’s **top-selling insecticide**, with **over ₹100 crores in sales (FY24)**, now a **Focus Maharatna** product.
- **Izuki, Hachiman, Pulsor**: Premium Japanese-origin brands now **registered under IIL’s own brand** with exclusivity.
- **Torry Super (2024)**: A 9(3) herbicide for maize using in-house SPF technology, receiving strong market traction.
- **‘Make in India’ Success Stories**:
- A 2016-launched paddy herbicide is now the **second-largest domestic brand**, covering over **170 lakh acres**.
- A 2023 launch became a **top-3 brand** in its category in under a year.
#### **Premiumization Strategy: Maharatna & Focus Maharatna**
IIL's growth is driven by its **premium product portfolio**:
- **Maharatna** and **Focus Maharatna** products now account for **~65% of sales**.
- As of Q1 FY25, **16 products** are in the **Focus Maharatna** range (up from 12), with 4–5 new entries expected annually.
- These products target **30–40% gross margins**, significantly above industry averages.
- Recent additions include **Altair, Centran SC, Brahmos, Torry Super, Terrox**, and **Hercules**.
#### **Market Reach & Distribution**
- IIL has **pan-India distribution** through:
- **8,500+ distributors**
- **70,000+ dealers & retailers**
- Serves **~4 million farmers**, connected via direct outreach and digital tools.
- **B2C** accounts for **~65% of revenue**, **B2B ~25%**, and **exports ~5%** (targeted to grow).
- Expanding focus on **maize, sugarcane, vegetables, soybean**, and **pulses** to diversify beyond traditional crops.
#### **Farmer Engagement & Digital Outreach**
- Conducts **thousands of farmer meetings, demonstrations, and field days** annually.
- Educational sessions **live-streamed on social media** in regional languages.
- **QR codes on packaging** provide instant access to batch details, expiry, and safety guidelines.
- Active presence on **YouTube, Facebook, Instagram, LinkedIn, and Twitter**.
#### **Financial & Operational Highlights**
- **FY24 Performance**:
- **9% revenue growth**, **62% YoY increase in net profit** to **₹102 crores**.
- New products (launched post-2020) contributed **~₹500 crores** (~1/3 of brand revenue).
- **Export Business**:
- Generated **₹94 crores in FY23**, with **162+ international registrations**.
- Targeting **₹250 crores** in exports, with presence in **24+ countries**.
- Low export costs due to **shared R&D data** for regulatory compliance.
#### **Acquisition & Diversification**
- **Acquisition of Kaeros**:
- Acquired for ₹5–6 crore.
- Delivered **₹2 crore profit** in first year.
- Projected to generate **₹10–12 crores** in FY25, with **exponential growth expected**.
- **IIL Biologicals Limited**:
- Wholly-owned subsidiary focused on **bio-pesticides, bio-fertilizers, microbial products, and nano-technologies**.
- Plants in **Shamli** and **Chopanki**, with a new facility planned at **Sotanala**.
#### **Strategic Shifts**
- **Phasing out generic AIs** due to **Chinese competition and price volatility** — **6 technicals discontinued**, but 90% of brands continue.
- Shifting focus from **low-margin legacy products** to **high-value, patented formulations**.
- **Reverse engineering program** accelerating first-in-India manufacturing (9/3 category launches).
- Strengthening capabilities in **biologicals and nano-agrochemicals** for future growth.
---
### **Leadership & Vision**
- **Chairman**: **Mr. Jayaraman Swaminathan** – 50+ years of global experience in agrochemicals and pharmaceuticals (ex-Hoechst, Aventis, Bayer).
- **Growth Vision**:
- Become a **full-stack, end-to-end solution provider** for farmers.
- Strengthen **‘Make in India’** positioning with **import substitution and local innovation**.
- Scale **premium product portfolio**, **biologicals**, and **international presence**.
- Focus on **sustainability, digital engagement, and farmer-centric R&D**.
---
### **Key Strengths**
1. **Trusted ‘Tractor’ Brand** with deep farmer connect.
2. **Backward integration** via AI synthesis plants.
3. **Proprietary, high-margin product portfolio** (Maharatna/Focus Maharatna).
4. **Exclusive global partnerships** with Japanese and U.S. innovators.
5. **Robust in-house R&D and JV for new molecule discovery**.
6. **Strong distribution network** across urban and rural India.
7. **Digital farmer engagement and QR code traceability**.
8. **Sustainability initiatives** — solar energy, wastewater recycling.